No verdict after 4th day of deliberations in Shkreli trial

Former pharmaceutical company CEO Martin Shkreli, left, walks out of federal court with his attorney Benjamin Brafman, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)
Martin Shkreli arrives to federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)
Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)
Former pharmaceutical company CEO Martin Shkreli, right, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)
Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)
Former pharmaceutical company CEO Martin Shkreli, second from left, walks out of federal court with his legal team Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)
Former pharmaceutical company CEO Martin Shkreli stands at an intersection after leaving federal court with his legal team, Thursday, Aug. 3, 2017, in New York. Jurors were on their fourth day of deliberations on Thursday at the securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Julie Jacobson)
Martin Shkreli arrives at federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)
Martin Shkreli, left, and his attorney Benjamin Brafman arrive to federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)
Martin Shkreli, second from left, arrives at federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)
Martin Shkreli arrives to federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)
Martin Shkreli arrives to federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

NEW YORK — Jurors have failed to reach a verdict after the fourth day of deliberations in the securities fraud trial of former pharmaceutical company CEO Martin Shkreli (SHKREL'-ee).

Deliberations will resume Friday in federal court in New York City.

Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.

The former biotech CEO, nicknamed "Pharma Bro," is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.

If convicted of the most serious charges, he could face up to 20 years in prison, but likely would receive far less time under sentencing guidelines.

Must Read

Visa holders rush to board flights to US amid reprieve

Feb 5, 2017

Visa holders from seven majority-Muslim countries affected by President Donald Trump's travel ban are hurrying to board U.S.-bound flights following a federal judge's order temporarily blocking the ban

Megyn Kelly leaving Fox News, will host 2 shows on NBC

Jan 4, 2017

Megyn Kelly, the Fox News star whose 12-year stint has been marked by upheavals at her network and personal attacks on the campaign trail, is headed to NBC News in a multi-year agreement

The Latest: Police: About 20 fires set at Dakota Access camp

Feb 23, 2017

Authorities in North Dakota say Dakota Access pipeline protesters set about 20 fires on the day their longstanding camp was scheduled for closure

People also read these

Visa holders rush to board flights to US amid reprieve

Feb 5, 2017

Visa holders from seven majority-Muslim countries affected by President Donald Trump's travel ban are hurrying to board U.S.-bound flights following a federal judge's order temporarily blocking the ban

Megyn Kelly leaving Fox News, will host 2 shows on NBC

Jan 4, 2017

Megyn Kelly, the Fox News star whose 12-year stint has been marked by upheavals at her network and personal attacks on the campaign trail, is headed to NBC News in a multi-year agreement

The Latest: Police: About 20 fires set at Dakota Access camp

Feb 23, 2017

Authorities in North Dakota say Dakota Access pipeline protesters set about 20 fires on the day their longstanding camp was scheduled for closure